Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 12 matching records.
12 results — page 1 of 1
- Level DLaboratory StudyPubMed
Quantitative proteomic and functional comparison of extracellular vesicles from multiple adipose tissue mesenchymal stem cell donors.
Laboratory Study on Chronic Inflammation, Immune Modulation, published in Extracell Vesicles Circ Nucl Acids (2026) — summary generated from the PubMed abstract.
- 2026
Extracell Vesicles Circ Nucl Acids - Level DNarrative ReviewEurope PMC
Stem cell-derived extracellular vesicles as immunomodulatory agents: targeting pathological crosstalk in systemic lupus erythematosus and multiple sclerosis
Narrative Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Front Med (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
Front Med (Lausanne) - Level DNarrative ReviewEurope PMC
Extracellular Vesicles in Multiple Sclerosis: Their Significance in the Development and Possible Applications as Therapeutic Agents and Biomarkers
Narrative Review on Neuroinflammation, Autoimmune Research, published in Genes (Basel) (2024) — summary generated from the PubMed abstract.
- 2024
Genes (Basel)5 citations - Level DNarrative ReviewEurope PMC
Extracellular Vesicles Derived from Mesenchymal Stem Cells Promote Wound Healing and Skin Regeneration by Modulating Multiple Cellular Changes: A Brief Review
Narrative Review on Chronic Wound, Immune Modulation, published in Genes (Basel) (2023) — summary generated from the PubMed abstract.
- 2023
Genes (Basel)24 citations - Level DNarrative ReviewEurope PMC
Extracellular Vesicles: Emergent and Multiple Sources in Wound Healing Treatment
Narrative Review on Chronic Wound, Scar, published in Int J Mol Sci (2023) — summary generated from the PubMed abstract.
- 2023
Int J Mol Sci7 citations - Level DNarrative ReviewPubMed
Harnessing the therapeutic potential of mesenchymal stem/stromal cell-derived extracellular vesicles as a novel cell-free therapy for animal models of multiple sclerosis.
Narrative Review on Neuroinflammation, Immune Modulation, Autoimmune Research, published in Exp Neurol (2023) — summary generated from the PubMed abstract.
- 2023
Exp Neurol - Level DNarrative ReviewEurope PMC
Multiplexed targeting of microRNA in stem cell-derived extracellular vesicles for regenerative medicine
Narrative Review on Face & Skin, Systemic / IV, published in BMB Rep (2022) — summary generated from the PubMed abstract.
- 2022
BMB Rep3 citations - Level DNarrative ReviewEurope PMC
Multiplexed strategies toward clinical translation of extracellular vesicles
Narrative Review, published in Theranostics (2022) — summary generated from the PubMed abstract.
- 2022
Theranostics41 citations - Level AMeta-analysisEurope PMC
Mesenchymal stromal cell extracellular vesicles for multiple sclerosis in preclinical rodent models: A meta-analysis
Meta-analysis on Neuroinflammation, published in Front Immunol (2022) — summary generated from the PubMed abstract.
- 2022
Front Immunol21 citations - Level DAnimal StudyPubMed
Multiplexed targeting of miRNA-210 in stem cell-derived extracellular vesicles promotes selective regeneration in ischemic hearts.
Animal Study on Cardiovascular Disease, published in Exp Mol Med (2021) — summary generated from the PubMed abstract.
- 2021
Exp Mol Med25 citations - Level DNarrative ReviewEurope PMC
Extracellular Vesicles in Multiple Sclerosis: Role in the Pathogenesis and Potential Usefulness as Biomarkers and Therapeutic Tools
Narrative Review on Neuroinflammation, published in Cells (2021) — summary generated from the PubMed abstract.
- 2021
Cells33 citations - Level DAnimal StudyPubMed
Therapeutic potential of extracellular vesicles derived from human mesenchymal stem cells in a model of progressive multiple sclerosis.
Animal Study on Neuroinflammation, Immune Modulation, published in PLoS One (2018) — summary generated from the PubMed abstract.
- 2018
PLoS One
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406